Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy

Di Wang; Xia Mao; Yimei Que; Menglei Xu; Yuhang Cheng; Liang Huang; Jue Wang; Yi Xiao; Wen Wang; Guang Hu; Shangkun Zhang; Tongcun Zhang; Chunrui Li; Jianfeng Zhou

doi:10.1038/s41408-021-00563-8

Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy

Blood Cancer J. 2021 Oct 18;11(10):168. doi: 10.1038/s41408-021-00563-8.

Authors

Di Wang^#^{1

2}, Xia Mao^#^{1

2}, Yimei Que^{1

2}, Menglei Xu^{1

2}, Yuhang Cheng^{1

2}, Liang Huang^{1

2}, Jue Wang^{1

2}, Yi Xiao^{1

2}, Wen Wang³, Guang Hu³, Shangkun Zhang^{4

5}, Tongcun Zhang^{4

5}, Chunrui Li^{6

7}, Jianfeng Zhou^{8

9}

Affiliations

¹ Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
² Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China.
³ Nanjing IASO Biotherapeutics Ltd, Nanjing, Jiangsu, 210032, China.
⁴ College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.
⁵ Wuhan Bio-Raid Biotechnology Co., Ltd., Wuhan, Hubei, China.
⁶ Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. cunrui5650@hust.edu.cn.
⁷ Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China. cunrui5650@hust.edu.cn.
⁸ Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. jfzhou@tjh.tjmu.edu.cn.
⁹ Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China. jfzhou@tjh.tjmu.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Clinical Trial
Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Female
Follow-Up Studies
Humans
Immunotherapy, Adoptive*
Male
Middle Aged
Multiple Myeloma* / immunology
Multiple Myeloma* / therapy
Multiple Myeloma* / virology
Receptors, Chimeric Antigen / immunology*
Registries
Virus Diseases* / etiology
Virus Diseases* / immunology

Substances

Receptors, Chimeric Antigen